Hematological Malignancies

RICOVER-60-no-RT

per protocol Analysis

25% difference

PFS

OS

EFS

90% [95%-CI: 84-97]

88% [95%-CI: 80-95 ]

80% [95%CI: 71-89 ]

65% [95%-CI: 49-81 ]

62% [95%-CI: 46-78 ]

54% [95%-CI: 38-71 ]

p=0.001

p=0.001

p<0.001

months

(n=78)

RICOVER-60

RICOVER-60-no-RX

(n=35)

Held , JCO 2014